News

Filter

Current filters:

Alcon

1 to 9 of 133 results

FDA approves Alcon's Pazeo for ocular allergy itch relief

FDA approves Alcon's Pazeo for ocular allergy itch relief

02-02-2015

The US Food and Drug Administration has approved Pazeo (olopatadine hydrochloride ophthalmic solution)…

AlconHealthHealth Medical PharmaNovartisOlopatadine hydrochlorideOphthalmicsPharmaceuticalUSA

Akorn files ANDA for generic Durezol

16-01-2015

US generic drugmaker Akorn has confirmed that it has filed an Abbreviated New Drug Application (ANDA)…

AkornAlconDurezolGenericsNovartisOphthalmicsPatentsRegulationUSA

Novartis' Alcon granted additional pediatric indication by the European Commission for Travatan

Novartis' Alcon granted additional pediatric indication by the European Commission for Travatan

23-12-2014

Eyecare specialist Alcon, the second-largest division of Swiss drug major Novartis, has been granted…

AlconNovartisOphthalmicsPharmaceuticalRegulationTravatanUSA

Novartis’ strong third-qtr boosted by sale of Idenix stake

Novartis’ strong third-qtr boosted by sale of Idenix stake

28-10-2014

Swiss pharma major Novartis this morning reported that sales for the third quarter of 2014 rose 4% to…

AlconFinancialNovartisPharmaceuticalSandozSwitzerland

Alcon’s Simbrinza approved for glaucoma in the EU

Alcon’s Simbrinza approved for glaucoma in the EU

28-07-2014

Eyecare specialist Alcon, a division of Swiss drug major Novartis, says its Simbrinza eye drops suspension…

AlconEuropeEuropean CommissionGlaucomaOphthalmicsPharmaceuticalRegulationSimbrinza

Novartis 2nd-qtr sales and net profit up but miss analysts’ forecasts

Novartis 2nd-qtr sales and net profit up but miss analysts’ forecasts

17-07-2014

Switzerland’s Novartis – now the world’s largest pharmaceutical company by sales - this morning…

AlconFinancialNovartisPharmaceuticalSandoz

EMA/CHMP backs Alcon’s Simbrinza for glaucoma

25-05-2014

Swiss drug major Novartis’ eye care division Alcon says that the European Medicines Agency’s Committee…

AlconEuropeNovartisOphthalmicsPharmaceuticalRegulationSimbrinza

Novartis 1st-qtr net profit flat, sales shy of forecasts

Novartis 1st-qtr net profit flat, sales shy of forecasts

24-04-2014

Swiss drug major Novartis posted a solid set of first-quarter 2014 financials this morning, showing that…

AlconFinancialNovartisPharmaceuticalSandoz

1 to 9 of 133 results

COMPANY SPOTLIGHT

Menarini

Back to top